Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oil-water interface in the gut lumen is the boundary formed during intestinal digestion when emulsified dietary lipids (from bile and peristalsis) coexist with the aqueous environment of the gastrointestinal tract[2]. This physical interface is where key enzymatic hydrolysis of lipids occurs, primarily via pancreatic lipase, which requires the presence of bile salts and colipase to act efficiently on triglyceride droplets. Proper function of this interface enables micellization and subsequent absorption of fats and fat-soluble nutrients into enterocytes. Disturbance in its formation or function, such as in bile acid deficiency or pancreatic enzyme insufficiency, leads to malabsorption syndromes but the interface itself is not a drug target, molecule, or receptor[2][8].
null (interface is a process, not a drug target; bile salts and lipases act at the interface to facilitate digestion[2][8])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oil-water interface in gut lumen.